Composer classification list. American Music Teacher | April 1, 2005 | COPYRIGHT 2005 Music Teachers National Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information) Copyright

 
This list is not exclusive. If you have repertoire 
concerns, contact the appropriate national coordinator. 
Baroque (B); Classical (C); Romantic 
(R); Impressionistic (I); Contemporary (Con) 
 
Achron, Joseph                Con 
Albeniz, Isaac                R 
Albeniz, Mateo                C 
Albrechtsberger, Johann       C 
Aquado                        R 
Arban,Jean-Baptiste           R 
Artunian,Alexander            Con 
Bach, C.P.E.                  C 
Bach, J.S.                    B 
Bach, J.C.                    C 
Bach, W.F.                    C 
Bach-Busoni                  ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

	Cortex to Raise $14.2 Million in Registered Direct Offering. Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR...Under the terms of the transaction, Cortex expects to sell an aggregate of approximately...in connection with the transaction. Cortex plans to use the net proceeds from this...
	Cortex Receives NYSE Amex Staff Determination. Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (NYSE Amex...Currently patient enrollment is underway in Cortex's clinical trial of CX1739 in patients...diabetes. Also, recent studies with Cortex's High Impact AMPAKINE molecules in...
	Cortex Pharmaceuticals Announces Management Changes. Business Wire ; ...Chairman of the Board IRVINE, Calif. -- Cortex Pharmaceuticals, Inc.'s (AMEX: COR...Officer and Chief Scientific Officer of Cortex since January 2006 and has served as a...With the assistance of Dr. Varney, Cortex has filed key new patents for the AMPAKINE...
	Cortex Completes $14.2 Million Registered Direct Offering. Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR...transaction resulted in gross proceeds to Cortex of approximately $14.2 million, excluding...prospectus supplement that form a part of Cortex's effective shelf registration statement...
	Cortex's CEO Roger Stoll to Speak at the Roth Capital Partners New York Conference on September 5, 2007.(Conference news) Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR...including the recent FDA response that gave Cortex the go-ahead to immediately resume...clinical developments and strategies. Cortex plans to file an Investigational New...
	Cortex and the University of California, Irvine Extend Exclusive Licensing Agreement. Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX:COR...Irvine (UCI). Under this Amendment, Cortex has extended the date for the filing...country, until October 10, 2012. "Cortex and UCI have enjoyed an excellent working...
	Cortex Announces Second Quarter Fiscal 2003 Results. PR Newswire ; Cortex Pharmaceuticals, Inc. announced the results...For the quarter ended December 31, 2002, Cortex reported a net loss of $276,000 ($0...October 2002 Servier agreed to supplement Cortex's existing research support by $4,000...
	Cortex Reports Fourth Quarter and Year End Operating Results.(Financial report) Business Wire ; IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR...fiscal year ended December 31, 2006, Cortex reported a net loss of $16,055,000...expenses, including amounts recorded for Cortex's Phase IIa clinical study in Attention...
	Cortex to Provide Shareholder Update and Host Conference Call on October 31, 2007.(Clinical report) Business Wire ; Cortex's AMPAKINE[R] Technology Featured in...Magazine Focused on Memory IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR) will...announcement on October 11, 2007. Although Cortex has not yet received the formal written...
	Cortex Announces Third Quarter Fiscal 2003 Results. Business Wire ; ...BUSINESS WIRE)--May 15, 2003 Cortex Pharmaceuticals, Inc. (AMEX:COR...For the quarter ended March 31, 2003, Cortex reported a net loss of $140,000...operating expenses. In October 2002, Cortex expanded Servier's rights to the AMPAKINE...

For more facts and information, see all results

Find more facts and information related to the article "Composer classification list."